Studies | EBMT

Top

Study type

Disease

Group

Type of transplant

Text

Prospective study on the incidence and outcome of HHV-6 encephalitis in patients who undergo allogeneic haploidentical HSCT

Non-interventional Prospective Studies

Complications: infectious

Infectious Diseases Working Party (IDWP)

Type of Stem Cell Treatment

Allogeneic - Haploidentical

Principal investigator

Katia Perruccio

Non-Tuberculous Mycobacterial infections post-hematopoietic stem cell transplantation

Retrospective Studies

Complications: infectious

Infectious Diseases Working Party (IDWP)

Type of Stem Cell Treatment

Principal investigator

Retrospective study on the incidence and outcome of Adenovirus infections in patients who undergo haploidentical SCT

Retrospective Studies

Infectious Diseases Working Party (IDWP)

Type of Stem Cell Treatment

Allogeneic - Haploidentical

Principal investigator

Survey on Protective Environment in HSCT settings

Complications: infectious

Nursing Research Committee

Infectious Diseases Working Party (IDWP)

Type of Stem Cell Treatment

Principal investigator

Infection prevention and control nursing practice and training needs assessment in BMT units in Low and Middle Income Countries (LMICs) – A cross sectional survey

Complications: infectious

Nursing Research Committee

Infectious Diseases Working Party (IDWP)

Type of Stem Cell Treatment

Principal investigator

Jacqui Stringer, Iris Agreiter

Central nervous system disorders following hematopoietic stem cell transplantation: a prospective observational study from the Infectious Diseases Working Party (IDWP) and the Transplant Complications Working Party (TCWP)

Non-interventional Prospective Studies

Complications: infectious

Complications: non-infectious

Infectious Diseases Working Party (IDWP)

Transplant Complications Working Party (TCWP)

Type of Stem Cell Treatment

Principal investigator

Martin Schmidt-Hieber

A Phase III Randomized, Placebo-controlled Clinical Trial to Evaluate the Safety and Efficacy of MK-8228 (Letermovir) for the Prevention of Clinically Significant Human Cytomegalovirus (CMV) Infection in Adult, CMV-Seropositive Allogeneic Hematopoietic Stem Cell Transplant Recipients

Clinical Trials Phase I-III

Complications: infectious

Infectious Diseases Working Party (IDWP)

Transplant Complications Working Party (TCWP)

Type of Stem Cell Treatment

Principal investigator

Impact of pre-existing invasive aspergillosis on allogeneic hematopoietic stem cell transplantation for treatment of acute leukaemia and myelodysplastic syndrome

Non-interventional Prospective Studies

Myelodysplastic (MDS) or MDS/MPN

Acute Myeloid Leukaemia (AML)

Acute Lymphatic Leukaemia (ALL)

Infectious Diseases Working Party (IDWP)

Type of Stem Cell Treatment

Principal investigator